Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3272204 A
Publication typeGrant
Publication date13 Sep 1966
Filing date22 Sep 1965
Priority date22 Sep 1965
Publication numberUS 3272204 A, US 3272204A, US-A-3272204, US3272204 A, US3272204A
InventorsArtandi Charles, Bechtol Lavon Dee
Original AssigneeEthicon Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
US 3272204 A
Abstract  available in
Images(2)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Sept 13, 1966 .2 c. ARTANDI ETAL 3,272,204

ABSORBABLE COLLAGEN PROSTHETIC IMPLANT WITH NON-ABSORBABLE REINFORCING STRAND-S Original Filed March 1, 1961 2 Sheets-Sheet 1 INVENTORS. (Iv m2 E5 /4 P74/VD/ Ara/v 052-" (554W 704.

ATTO R N EY pt. 13, 1966 c. ARTANDI ETAL 3,272,204

ABSORBABLE COLLAGEN PROSTHETIC IMPLANT WITH NON-ABSORBABLE REINFORCING STRANDS Original Filed March 1, 1961 2 Sheets-Sheet 2 INVENTOR'S. (7 4/6455 4/? r4/v0/ Zmgo /v 0E6 550/;

ATTORNEY United States Patent 3,272,204 ABSDRISABLE CDLLAGEN PRGSTHETIC IM- PLANT WITH NON-ABSOABLIE REIN- FORQTNG STRANDS Charles Artandi, Highiand Park, N..I., and Lavon Dee Bechtel, Indianapolis, Ind., assignors to Ethicon, Inc., a corporation of New Jersey Continuation of application Ser. No. 92,620, Mar. 1, 1961. This application Sept. 22, 1965, Ser. No. 495,010 Claims. (Cl. 128334) This application is a continuation of copending application Serial No. 92,620, filed March 1, 1961, now abandoned.

The present invention relates to reinforced collagen prostheses adapted to be placed permanently in the human body, and to a method of making the same. More particularly, this invention relates to collagen articles that are reinforced with non-absorbable fabrics.

In the surgical repair of hernias, tantalum gauze and inert fabrics have found considerable use, particularly in older patients who are recognized to have a reduced ability to rebuild tissue at the point of surgery. Tantalum gauze, however, has the undesirable property of work hardening and may curl up within the body, causing discomfort. Inert fabric prostheses have the disadvantage that they do not becomea part of the body tissues. Such inserts frequently remain surrounded by a pool of sera after the healing process. A suitable prostheses for strengthening the repair should be non-toxic, flexible and porous. The ideal prostheses should retain its strength permanently in intimate contact with body fluids and should be readily accepted and incorporated into the tissue. Porosity is an important characteristic of such a prosthesis to avoid the formation of fluid pockets and to promote the growth through the fabric of repair tissue.

The present invention has for its principal object the provision of flexible films and tubes constructed of collagen and reinforced with an open mesh, non-absorbable fabric that is compatible with the human body.

A further object of the invention is the provision of such flexible tubes that are not subject to kinking or collapsing in any desired diameter or length suitable for use with human arteries or veins.

Another object is the manufacture of prostheses having a structure which promotes the growth of body tissue into and through the prostheses during the healing process.

It has now been discovered that an improved prostheses can be constructed using as a framework or support a non-absorbable plastic material, knitted, woven or braided to have a wide mesh, thus permitting easy invasion by the host into the interstices between the non-absorbable fibers. In the improved prostheses of the present invention, the interstices between the non-absor-bable fibers are initially filled and rendered blood tight by collagen fibrils. The collagen fibrils have considerable tensile strength, are non-antigenic, are slowly absorbed and permit satisfactory in-growth of fibroblasts and endothelial cells, resulting in attachment of the prosthesis to the host tissues. Since collagen is the type of connective tissue normally laid down by the body during the healing process, there is no appreciable decrease in the strength of the prosthesis during the period that the collagen fibrils are being replaced.

The invention will appear more clearly from the following detailed description when taken in connection with the accompanying drawings, showing by way of example, a preferred embodiment of the inventive idea. Referring now to the drawings:

FIGURE 1 is a view of a reinforced collagen film. In this view, the surface collagen films have been forcibly ice pulled away from the n-on-absorbable fabric to illustrate the laminated construction.

FIG. 2 is a greatly enlarged view of the non-absorbable fabric that forms the reinforcing central element of the structure illustrated by FIG. 1.

FIG. 3 is a view of a fabric mesh tube reinforced with a plastic helix.

FIG. 3a is a view in section of a fabric mesh tube reinformed with a plastic helix on the line 3a-3a of FIG. 3.

FIG. 3b is a large scale fragmentary sectional view of FIG. 3 showing a method of supporting a fabric tube in accordance with a feature of the instant invention.

FIG. 4 is a view, partially in section, of a fabric mesh tube reinforced with plastic rings and coated with collagen fibrils.

FIG. 5 is a view, partially in section, of a reinforced molded collagen tube.

The non-absorbable fabric that is used to reinforce the collagen prostheses of the present invention may be knit, woven, crocheted or braided in the desired shape of any synthetic or natural fibers that are compatible with the human body. Examples of suitable materials are Vinyon-N, a resin manufactured by the Carbide and Carbon Corporation by copolymerizing vinyl chloride and acrylonitrile; nylon, a polyamide resin made by polymerization of the hexamethylene diamine salt of adipic acid; Orlon, a synthetic fiber made by the E. I. du Pont de Nemours & Go, from polyacrylonitrile; Dacron, a synthetic fiber made by the E. I. du Pont de Nemours & Go, from terephthalic acid and ethylene glycol; Teflon, a tetrafluoroethylene polymer manufactured by the E. I. du Pont de Nemours & 00.; cotton and silk. Dacron and T efion are particularly preferred because both have displayed excellent retention of tensile strength over long periods of time and both are essentially inert. Teflon being slightly more inert and slightly stronger than Dacron.

The non-absorbable fabrics may be knitted, crocheted, woven or braided in the shape of the desired prosthesis as a film, tube, Y-tube, et-c. Optionally, a film of the fabric may be rolled or cut and sewed with suitable thread to form the desired shape. The fabric may be further strengthened by plastic rings as illustrated in FIG. 4. It is important that the mesh of the non-absorbable fabric be sufficiently open to permit the collagen fibrils to extend into and through the interstices of the fabric. These collagen fibrils that pass through the fabric cohere to the collagen fibrils on either side of the fabric framework and form a unitary structure that resists delamination.

After the fabric framework has been constructed in the desired shape, it is coated on both sides with a collagen mass obtained by swelling collagen fibrils in an aqueous acid solution. The swollen collagen fibrils are then frozen in position and deswollen by dehydration in an organic solvent.

The improved prostheses of the present invention may also be manufactured by an alternate process consisting of knitting, weaving, crocheting or braiding together an inert non-absorbable thread or yarn with collagen yarn or collagen multifilament. A suitable fabric can be woven with warp yarns of Dacron or Teflon and filling yarns of collagen. The preparation of a collagen multifilament suitable for such use is described in United States patent application Serial No. 768,969, filed October 22, 1958, abandoned in favor of continuing appli cation Serial No. 102,533, filed April 12, 1961, now Patent No. 3,114,372.

It will be understood that the collagen present in the prostheses of the present invention may be treated with tanning agents such as formaldehyde, pyrogallol, chromium, etc., by methods well known in the art to obtain increased strength and control the rate at which the collagen will be absorbed.

The present invention is more fully described and exemplified in the following examples. It is to be understood, however, that our invention is not to be limited to any specific form of materials or conditions set forth n the examples, but is limited solely by the description in this specification and the appended claims. Throughout the specification and the examples which follow, all quantities are expressed in parts by weight.

EXAMPLE I The deep flexor tendon of cattle is cleaned of fat, superficial non-collagenous protein and other extraneous matter and is Sliced on an electric meat-slicing machine (rotary knife) in the frozen condition. The tendon sections are sliced perpendicularly to their longitudinal axis to a thickness of about 11 mils. An aliquot sample of the tendon slices is analyzed; the dry solids amounts to The sliced tendon is next treated with an enzyme solution to dissolve elastin. The enzyme solution is prepared by dissolving 0.15 part of ficin and 3.75 parts of ethylene diamine tetrasodium tetraacetate in 750 parts of water. Seventy-five parts of the sliced tendon is immersed in this solution which is stored at room temperature overnight. Then 2.25 parts of 30% hydrogen peroxide is added to destroy any residual ficin.

To this mixture of tendon slices in about 750 parts of water is added an additional 2244 parts of water and 5.87 parts of cyanoacetic acid. The swelling solution is cooled to below 25 C. This mixture is stirred in a dispersion kettle at about 60 r.p.m. The remaining steps in the proceSs are carried out at temperatures below about 25 C. and the temperature of the collagen dispersion is not allowed to exceed this temperature.

Stirring is continued for about 3 hours, during which time the individual collagen slices are swollen. The dispersion is then homogenized by repeated passes through series-connected jets having orifices of 50 mils and 40 mils respectively. The dispersion is then forced through a leaf filter containing three screens of #316 stainless steel. These screens are separated by Aa-inch spacers and decrease in mesh size so that the dispersion first passes a 14- mil screen, then a 9-mil screen, and finally a 4-mil screen. The dispersion of swollen solvated collagen fibrils so obtained analyzes 1.09% solids and has a pH of 2.52.

The above collagen dispersion (300 grams) is poured into a stainless-steel tray measuring x 9" x 1 /2" and smoothed out. A Dacron tulle is placed flat on the surface of the collagen dispersion and covered with another 300 grams of collagen dispersion. The tray is frozen in a sub-zero cabinet at C. overnight. The frozen sandwich is then removed from the tray and immersed in a circulating bath containing 5 liters of 99% isopropanol and milliliters of concentrated ammonium hydroxide at room temperature. After approximately four hours, the isopropanol solution is replaced with 5 liters of a fresh solution and the dehydration is continued overnight at room temperature. The isopropanol solution containing the water extracted is removed and a third bath of 99% isopropanol is used in the further dehydration of the collagen. The third bath is replaced in turn with a fourth bath of 99% isopropanol containing 0.4% formaldehyde, the dehydrating time amounting to 6 to 8 hours in both the third and fourth baths. At this time, the collagen fibrils are practically free of water and the Dacron-collagen film may be squeezed repeatedly between rubber rollers and air-dried in an oven at C. overnight without damage.

The product so obtained is illustrated in FIGURE 1. The collagen fibrils of the surface coatings 11 and 12 extend through the openings 13 in the fabric 14 and make it difficult to separate the collagen layer from the fabric.

4 EXAMPLE II A collagen dispersion is prepared according to the general procedure described in Example I above from 391 parts of sliced beef leg tendon and 17,110 parts of distilled Water containing 7.3 parts of glacial acetic acid. This dispersion contains 0.8% solids and is placed in trays and reinforced by immersing a Teflon fabric in the dispersion so that the fabric is suspended about halfway between the sur-face of the dispersion and the bottom of the tray. The contents of each tray is frozen and transferred in the frozen condition to a wire mesh frame. The frozen mass from each tray is dehydrated and coagulated by immersing in a circulating bath containing 60,000 parts of 99% isopropanol, 300 parts of concentrated ammonium hydroxide and 240 parts of formaldehyde (37% solution) at room temperature for approximately 8 hours. The circulating isopropanol bath is then replaced with a freshly constituted bath and the dehydration is continued overnight. This second bath is replaced with a third bath containing 99% isopropanol at room temperature and the dehydration is continued for 8 to 16 hours after which a fourth bath consisting of 99% isopropanol is substituted for the third bath. After dehydration for 8 to 16 hours in the fourth bath, the collagen coated Teflon fabric is compressed at about 128 pounds per square inch pressure and air-dried at C. overnight.

EXAMPLE III Example II above was repeated, substituting for the 7.3 parts of glacial acetic acid employed in that example 59.5 parts of cyanoacetic acid. The resulting prosthesis is sterilized by electron beam irradiation and may be used by the surgeon for hernia repair.

EXAMPLE IV A collagen dispersion is prepared according to the general procedure described in Example I above from 216 parts of sliced beef leg tendon and 9,780 parts of distilled water containing 50 parts of malonic acid. This dispersion contains 0.8% solids and is used to coat both sides of a Teflon net fabric as described in Example I. The Teflon-collagen composition is frozen and transferred in the frozen condition to a wire mesh frame. The frozen mass is dehydrated and coagulated by immersing in a circulating bath containing 45,000 parts of 99% isopropanol and 1330 parts of concentrated ammonium hydroxide at room temperature for approximately 8 hours. The freshly constituted bath and the dehydration is continued overnight. This second bath is replaced with a third bath containing 99% isopropanol at room temperature and the dehydration is continued for 8 to 16 hours after which a fourth bath consisting of 99% isopropanol is substituted for the third bath. After dehydration in the fourth bath for 8 to 16 hours, the resulting product is air-dried at 50 C. overnight.

The film so obtained is tanned by immersing for 30 seconds 1n a solution of 0.4 part of pyrogallol, 0.1 part tetrasodium ethylenediamine tetraacetic acid and 99.5 parts of water adjusted to pH 8.3 with ammonium hydrox- 1de and redried in an oven at 50 C. for 6 hours.

The film is next immersed for 30 seconds in a solution .of chromium (III) sulfate comprising 0.8 part of chromium as chromic oxide, 0.5 part of lactic acid 0.24 part of formaldehyde and 98.46 parts of water adusted to pH 2.7 with sodium hydroxide, and dried in an oven at 50 C. overnight.

EXAMPLE V A glass tube having an inside diameter of about /1 inch is fitted With a one-hole stopper of rubber through which a A -inch glass rod is placed so that the glass rod extends coaxially within the glass tube. Before placing the glass rod and rubber stopper in position, the glass rod is covered With a piece of rubber tubing and a cylindrical tube of open-mesh woven Dacron about inch in diameter is slipped over the glass rod and rubber tube.

The glass tube and glass rod are assembled in an upright position with the bottom of the Dacron fabric tube resting on the rubber stopper. A dispersion of swollen collagen fibrils (0.08% collagen in 0.05 N acetic acid) is poured into the glass tube while maintaining the fabric tube in a coaxial position and equally spaced between the rubber tube and glass tube so that both sides of the fabric are coated with the collagen dispersion. This mold with the dispersion and fabric in place is then frozen in the vertical position for at least 4 hours at C.

The mold is then placed in a static coagulation bat-h consisting of 2 liters of isopropanol alcohol, cubic centimeters of concentrated ammonia (25%) and 10 cubic centimeters of formaldehyde (37% solution) at room temperature and the mold is maintained in the solution for 16 hours. The glass rod covered with the rubber tube and the formed collagen tube is then removed and placed in a dehydrating bath consisting of 2 liters of isopropanol alcohol. The collagen tube is left in this bath for an additional 16 hours to complete the dehydration.

After dehydration, the rubber tube with the collagen tube on it, is very carefully slid off the glass rod and the rubber tube is removed from the interior of the collagen tube by pulling 'on both ends of the rubber tube, thereby stretching the rubber tube and reducing its diameter. After the collagen tube is removed from the rubber tubing, it is plasticized in a bath consisting of 2 liters of 90% isopropanol alcohol (10% water) containing 5% glycerine. This plasticizing operation is optional. After 24 hours in the plasticizing bath, the collagen tube is supported on a glass rod and air-dried. The resulting product is illustrated in FIGURE 5.

EXAMPLE VI Tanned Dacron reinforced collagen films prepared by the method described in Example II above are rolled and sewed to form tubes about 1 centimeter in diameter and sterilized by irradiating with an electron beam. These tubes are used to replace segments of the abdominal aorta in mongrel dogs averaging 15 kilograms in weight. The animals were sacrificed at varying periods of time up to 8 months.

Grossly, the Dacron-collagen prothesis shows an orderly pattern of organization at varying periods of time following insertion of the graft. The prostheses are all 5 centimeters long, divided into two typesthick and thin,

according to the amount of impregnated collagen. N0 significant response difference can be detected in the two types. However, there is a significant difference, particularly in regard to initial hemorrhage, between the untreated collagen and the collagen that has been tanned. The following results are observed:

One week Gross specimen-The one-week specimens are contained in a fibrous envelope which is not in any Way adherent to the prosthesis. The interstices of the graft are still occlude-dby the impregnated collagen and the lumen is lined by a red, granular coagulum.

Microscopic section.Sections of the proximal portion show an artefactual separation of the Dacron prosthesis from the surrounding fibro-adipose tissue.

The fibre-adipose tissue shows active fibroplasia and a minimal inflammatory infiltrate, comprised of polymorphonuclear leukocytes, a few lymphocytes and some plasma cells. The prosthesis itself shows the open meshwork with the interstices filled by a series of haphazardlyarranged, tangled fibrils of bovine collagen with irregular interstices containing small numbers of erythrocytes. The surface of the prosthesis is covered by fibrin clot containing a few histiocytes, erythrocytes and neutrophils. There is no tongue-like extension of fibroplasia extending from the severed end of the aorta out into the graft, although there is a focal zone of reactive hyperplasia with capillaries and occasional inflammatory elements present at the anastomotic line. The lining consists of a thin fibrin layer, maximally 1 millimeter in thickness.

Two weeks Gross specimen.By two weeks, the fibrous envelope is partially adherent but may be readily dissected free by lysis of delicate fibrous and fibrinous bands. The wall of the prosthesis and the lining are similar to those of the one-week specimen.

Microscopic seclion.-The two-week specimen shows a lack of inflammatory reaction similar to the specimen at one week. The zone of fibrosis and fibroplasia in the fibro-adipose tissue adjoining the prosthesis is more mature, but as yet, there is no extension of fibroblasts into the prosthesis except at microscopic points. At the anastomosis, a well developed zone of fibroplasia extends across the anastomotic line onto the surface of the prosthesis and this tongue, in turn, is covered in part by endothelium. The prosthesis itself appears quite similar to the oneweek specimen. The impregnated collagen appears well retained. The lining surface of the prosthesis now appears to be more dense fibrin with enmeshed erythrocytes and is somewhat thinner than the fibrin lining of the oneweek specimen.

Three weeks Gross specimen.-At three weeks the fibrous envelope is more adherent than earlier, but still may be separated by forceful dissection. The lining is smoother and averages approximately one millimeter in thickness.

Microscopic section-The peripheral enveloping zone of fibrosis is wider than previously and there is extension of fibroblasts into the interstices of the prosthesis at numerous points. Foreign body reaction to the Dacron of the prosthesis is present but still remains minimal. The inflammatory reaction is largely composed of histiocytes containing hemosiderin, plasma cells and lymphocytes. A mural fibrin thrombus is present and is focally organiZed, particularly at the anastomotic line. This organization is part of the tongue of advancing fibroblasts.

Four weeks Gross specimen.-The four-week specimen is finely swedged to the fibrous envelope. A thin semi-transparent membrane covers the anastomotic lines.

Microscopic section.A dense, surrounding fibrous envelope of mature collagenous connective tissue stains bright green in a Masson trichrome stain. The prosthesis adheres densely to this envelope and there are irregular extensions of this material into the interstitial areas of the prosthesis, most particularly between the Dacron meshwork. The interstices of the bovine collagen are now partially filled with green-staining collagenous connective tissue from the host. Inflammatory reaction is meager. The lining of the prosthesis consists of a zone of fibrous tissue apparently covered by endothelium that ranges in thickness from about 1 millimeter to less than 0.1 millimeter, being thinnest in its more central extent. This lining is continuous with the lining of the dogs aorta.

Five weeks Gross specimen-The five-week specimen is essentially the same as the four-week specimen.

Microscopic secti0n.-The appearance is substantially the same as that of the four-week specimen, although there is slightly less of the bovine collagen remaining and more of green-staining collagen contributed by the host, particularly at the anastomosis.

Two-and-a-half months Gross specimen-The organization is almost complete. The fibrous envelope is firmly adherent and the lumen is lined by a thin, well-defined, smooth, semi-transparent grayish membrane.

Microscopic section-There is notable progress of the fibrous tissue ingrowth into the prosthesis. Only an occasional, longitudinally, oriented wavy thread of the original prosthetic impregnation remains.

Eight months Gross specimen.The prosthesis is solidly united to the fibrous envelope. In cross section, the entire thickness of the prosthetic wall is slightly less than 2 millimeters. The lumen is covered by a smooth, glistening, grayish membrane that appears continuous with the intima of the host artery.

Microscopic section.The prosthesis is completely organized by mature collagen that fills all of the interstices and has replaced all of the original bovine collagen fibrils except for a rare remaining fibril. The luminal aspect of the prosthesis is smooth and is continuous with the dogs aorta. There is virtually no inflammatory reaction. The Dacron material of the prosethetic meshwork appears embedded in a continuous, rather uniform collagen mass. Externally, the prosthesis blends with the adjoining fibroadipose tissue.

EXAMPLE VII A Teflon fabric 14 is rolled to form a cylinder'as indicated in FIGURE 3 and the fabric is sewed with Dacron thread 15 to a surrounding Teflon helix 16 as illustrated in FIGURE 3. The supporting helix prevents the fabric tube from kinking or collapsing. This structure is covered with collagen fibrils on both sides by the procedure outlined in Example V. The resulting tube resists fraying at the ends and is adapted for use in grafts that traverse the inguinal fold or the popliteal space.

EXAMPLE VIII A Dacron fabric 14 is sewed to form a cylinder as indicated in FIGURE 4 and the fabric is sewed with Dacron thread 15 to spaced surrounding Teflon rings 17 as illustrated in FIGURE 4. The supporting rings 17 serve the same function as the helix 16 in FIGURE 3 and prevents the fabric tube from kinking or collapsing. This structure is covered by collagen fibrils on both sides by the procedure outlined in Example V. The resulting article after electron beam sterilization is adapted for use in clinical vascular surgery. The finished tube is quite flexible and may be flexed repeatedly without collapsing.

EXAMPLE IX A collagen dispersion (0.86% solids) is extruded into a circulating acetone dehydrating bath through a stainless steel spinnerette drilled with 192 openings arranged in concentric circles. Each opening in the spinnerette is approximately 18 mils in diameter and each opening has a taper from this diameter at a point 34 mils from the spinnerette surface to a inch opening at the bottom surface of the spinnerette. The multifilament that emerges from the acetone dehydrating bath is wrapped 1 /2 times around a godet and passes to a false twister. Warm air is circulated to dry out the multifilament as it contacts the false twister which is rotated at about 200 r.p.m. Under these conditions, the individual filaments that make up the multifilament do not bond together. The multifilament, which consists of 192 individual collagen threads, may be collected directly on a takeup spool.

The collagen multifilament so obtained may be woven together with non-absorbable multifilament or yarn such as Dacron yarn to form fabrics and tubes that are useful in surgery. It is desirable that the collagen multifilament be tanned by methods well-known in the art to increase the strength and in vivo digestion time of the collagen. The collagen multifilament may be tanned prior to or after weaving. If the collagen multifilament is tanned prior to weaving, a collagen strand may conveniently be formed by twisting the collagen multifilament and drying under tension. Under these conditions, the individual filaments cohere to form a strand which may be woven into a fabric or tube with non-absorbable threads or yarn.

While the invention has been described in detail according to the preferred method of carrying out the process and yielding the products, it will be obvious to those skilled in the art, after understanding the invention, that changes and modifications may be made (without departing from the spirit or scope of the invention) and it is intended in the appended claims to cover such changes and modifications.

What is claimed is: 1. A method of manufacturing surgical prostheses which comprises the steps of:

impregnating a non-absorbable fabric with an aqueous acid dispersion of swollen collagen fibrils; freezing the aqueous acid dispersion of swollen collagen fibrils; immersing the frozen mass in a water-miscible organic solvent containing sufficient base to neutralize the acid present in said dispersion; removing the resulting structure from the organic solvent; and, drying the resulting structure. 2. A method of manufacturing surgical prostheses which comprises the steps of:

knitting an open mesh tube; impregnating this tube with an aqueous acid dispersion of collagen fibrils, whereby said collagen fibrils fill the interstices of the tube; freezing the aqueous acid dispersion of collagen fibrils; immersing the frozen mass in acetone containing suflicient ammonium hydroxide to neutralize the acid present in said dispersion, whereby the collagen fibrils are dehydrated and coagulated; removing the structure so obtained from the acetone;

and, drying. 3. A surgical prosthesis comprising: an open mesh non-absorbable fabric, manufactured of material selected from the group consisting of polyethylene terephthalate and tetra fluoroethylene polymer, and impregnated with a body absor-bable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight. 4. -A surgical prosthesis comprising: an open mesh non-absorbable tulle, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, the interstices of which are filled with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight. 5. A surgical prosthesis comprising: an open mesh non-absorbable cylindrical tube, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, and coated on at least one side with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight.

A surgical prosthesis comprising:

a knit open mesh non-absorba'ble cylindrical tube, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, and coated on at least one side with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight.

7. A surgical prosthesis comprising:

a woven open mesh non-absorbable cylindrical tube, manufactured of material selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer, and coated on both sides with a body absorbable substance consisting of collagen fibrils, whereby the prosthesis is rendered bloodtight.

'8. A surgical prosthesis comprising:

a non-absorbable tulle, manufactured of material selected from the group consisting of polyethylene t r phthalate and tetrafluoroethylene polymer, and

shaped to form a cylindrical tube; a plurality of reinforcing non-absonbable rings manufactured of tet rafiuoroethylene polymer surrounding and spaced along the axis of said tube; said tube being encapsulated in a matrix of collagen fibrils.

9. A surgical prosthesis comprising:

a non-absorbable fabric, manufactured of material selected from the group consisting of polyethylene terephthalate and tetraifluoroethylene polymer fabrics, and shaped to form a cylindrical tube; a nylon helix coiled around said tube; the tube and surrounding helix being coated with collagen fibrils.

10. A surgical prosthesis comprising a bloodtight knitted fabric consisting of a non absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafluoroethylene polymer yarn and mixtures thereof; and a body absonbable extruded multifilament consisting of collagen fibrils, the interstices between the non-absorbable yarn of the fabric being sufficiently large to permit easy invasion by the host tissue during the healing process.

1 1. A surgical prosthesis comprising a bloodtight fabric woven with filling yarns of non-absorbable threads selected from the group consisting of polyethylene terephthalate and tetrafluoroethylene polymer threads; and Warp yarns of body absorbable extruded strands consisting of collagen fibrils, the non-absorbable threads of the fabric being separated sufficiently from each other to permit easy invasion by the host tissue during the healing process.

12. A surgical prosthesis comprising a bloodtight fabric woven with tfilling yarns of non-absorbable threads selected from the group consisting of polyethylene terephthalate and tetrafluoroethy-lene polymer threads; and Warp yarns of a body absorbable extruded multifilamen-t consisting of collagen fibrils, the interstices between the nonabsorbable threads of the fabric being sufficiently lange to permit easy invasion by the host tissue during the healing process.

1 3. A surgical prosthesis comprising a bloodtight woven fabric consisting of a non-absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafiuoroethylene polymer yarn and mixtures thereof; and a body absorbable extruded multifilament consisting of collagen fibrils, the interstices between the non-absorb able yarn of the fabric being sufliciently large to permit easy invasion by the host tissue during the healing process.

14. A surgical prosthesis comprising a bloodtight braided fabric consisting of a non-absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafiuoroethylene polymer yarn and mixtures thereof; and a body absorbable extruded multifilament consisting of collagen fibrils, the interstices between the non-absorbable yarn of the fabric being sufficiently large to permit easy invasion by the host tissue during the healing process.

15. A surgical prosthesis comprising a bloodtight crocheted fabric consisting of a non-absorbable yarn selected from the group consisting of polyethylene terephthalate, tetrafluoroethy lene polymer yarn and mixtures thereof; and a body absonbable extruded multifilament consisting of collagen fibrils, the interstices between the non-a-bsorbable yarn of the fabric being sufficiently large to permit easy invasion by the host tissue during the healing process.

References Cited by the Examiner UNITED STATES PATENTS 2,072,302 3/ 1937 Hermann et al 12'8-335 .5 2,127,903 8/ 1938 =Bowen 128-334 2,453,056 11/1948 Zack 128-334 2,667,321 5/1953 Cresswell 128- 3355 2,671,444 3/ 1954 Pease 128-455 X 2,731,788 1/1956 Donaldson 2 8-7 6 2,827,359 3/1958 Kine et al 28-80 X 2,845,959 8/1958 Sidebotham 31 X 2,920,000 1/ 1960 Hochstadt et al. 260- 123] X 2,934,447 4/1960 Highbenger et al. 106-155 3,011,527 1 2/ 1961 Corbiere 1 393-87 3,014,024 12/ 1961 Lieberman et al. 260-l23.7

OTHER REFERENCES Progress in Synthetic Graft Development, Surgery, vol.

45, No. 2, pp. 298 309, February 1959.

RICHARD A. GAUDET, Primary Examiner.

D. L. TRULUOK, Assistant Examiner.

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,272,204 September 13, 1966 Charles Artandi et a1.

ppears in the above numbered pat- It is hereby certified that error a aid Letters Patent should read as ent requiring correction and that the s corrected below.

Column 4 line 46, after. "The" insert circulating isopropanol bath is then replaced with a Signed and sealed this 1st day of August 1967.

(SEAL) Attest:

EDWARD J. BRENNER Commissioner of Patents Edward M. Fletcher, Jr. Attesting Officer

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2072302 *3 Mar 19322 Mar 1937Chemische Forschungs GmbhPolymerized vinyl alcohol articles and processes of making same
US2127903 *5 May 193623 Aug 1938Davis & Geck IncTube for surgical purposes and method of preparing and using the same
US2453056 *12 Mar 19472 Nov 1948Edwin Zack WilliamSurgical anastomosis apparatus and method
US2637321 *27 Sep 19515 May 1953American Cyanamid CoShaped article and method of producing it
US2671444 *8 Dec 19519 Mar 1954Pease Jr Benjamin FNonmetallic mesh surgical insert for hernia repair
US2731788 *8 Oct 194924 Jan 1956CluettComposite thread.
US2827359 *22 Mar 195418 Mar 1958Rohm & HaasProcess for stabilization of protein textiles with 4-vinyl pyridine copolymers and products produced therefrom
US2845959 *26 Mar 19565 Aug 1958Sidebotham John BBifurcated textile tubes and method of weaving the same
US2920000 *22 Oct 19585 Jan 1960Ethicon Inc Ethicon IncRemovable valve Collagen article and the manufacture thereof
US2934447 *22 Oct 195726 Apr 1960United Shoe Machinery CorpCollagen fiber masses and methods of making the same
US3011527 *23 May 19575 Dec 1961RhodiacetaProsthesis consisting of textile materials
US3014024 *19 Mar 195819 Dec 1961Johnson & JohnsonCollagen film
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3366440 *3 Nov 196430 Jan 1968Ethicon IncProcess for manufacturing a collagen fabric-film laminate
US3400719 *9 Jun 196410 Sep 1968Albert O.L.J. Eckhart BuddeckePlastic graft material and method of making same
US3408659 *21 Jul 19655 Nov 1968Thiele HeinrichArtificial blood vessels and process of making same
US3425418 *15 Apr 19644 Feb 1969Spofa Vereinigte Pharma WerkeArtificial blood vessels and method of preparing the same
US3452366 *21 Jun 19661 Jul 1969Avco CorpPercutaneous conduit and connector
US3463158 *9 Jan 196726 Aug 1969American Cyanamid CoPolyglycolic acid prosthetic devices
US3479670 *19 Oct 196625 Nov 1969Ethicon IncTubular prosthetic implant having helical thermoplastic wrapping therearound
US3491760 *6 Jul 196627 Jan 1970Braun Intern Gmbh BWound coverings
US3514791 *25 Jul 19672 Jun 1970Charles H SparksTissue grafts
US3625198 *9 May 19697 Dec 1971Charles H SparksDie and holder for implanting in a living body to grow tissue grafts
US3862452 *21 Jun 197128 Jan 1975Ceskoslovenska Akademie VedHydrogel substitutes for tubular somatic organs
US3918099 *29 May 197411 Nov 1975Fettback HelmutArtificial organ or part or section thereof for implanation into the human body and method of producing the same
US4086665 *16 Dec 19762 May 1978Thermo Electron CorporationArtificial blood conduit
US4130904 *6 Jun 197726 Dec 1978Thermo Electron CorporationProsthetic blood conduit
US4182339 *17 May 19788 Jan 1980Hardy Thomas G JrAnastomotic device and method
US4229838 *3 Jul 197828 Oct 1980Sumitomo Electric Industries, Ltd.Vascular prosthesis having a composite structure
US4329743 *27 Apr 197918 May 1982College Of Medicine And Dentistry Of New JerseyBio-absorbable composite tissue scaffold
US4338926 *21 Nov 198013 Jul 1982Howmedica, Inc.Bone fracture prosthesis with controlled stiffness
US4361552 *26 Sep 198030 Nov 1982Board Of Regents, The University Of Texas SystemWound dressing
US4365357 *25 Apr 198028 Dec 1982Merck Patent Gesellschaft Mit Beschrankter HaftungSurgical materials suitable for use with bone cements
US4411027 *23 Feb 198225 Oct 1983University Of Medicine And Dentistry Of New JerseyBio-absorbable composite tissue scaffold
US4441215 *23 Feb 198310 Apr 1984Kaster Robert LVascular graft
US4457028 *14 Oct 19823 Jul 1984Merck Patent Gesellschaft Mit Beschrankter HaftungSurgical materials suitable for use with bone cements
US4501263 *31 Mar 198226 Feb 1985Harbuck Stanley CMethod for reducing hypertension of a liver
US4512038 *6 Apr 198123 Apr 1985University Of Medicine And Dentistry Of New JerseyBio-absorbable composite tissue scaffold
US4550447 *3 Aug 19835 Nov 1985Shiley IncorporatedVascular graft prosthesis
US4647416 *26 Apr 19853 Mar 1987Shiley IncorporatedMethod of preparing a vascular graft prosthesis
US4662884 *25 Apr 19845 May 1987University Of Utah Research FoundationProstheses and methods for promoting nerve regeneration
US4670286 *26 Dec 19852 Jun 1987Allied CorporationMethod of forming prosthetic devices
US4778467 *10 Jul 198618 Oct 1988The University Of UtahProstheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US4787391 *11 Aug 198729 Nov 1988Elefteriades John AAnastomotic marking device and related method
US4842575 *5 Aug 198827 Jun 1989Meadox Medicals, Inc.Method for forming impregnated synthetic vascular grafts
US4865031 *3 Oct 198812 Sep 1989Keeffe Paul J OFabric and method of use for treatment of scars
US4871365 *24 Dec 19863 Oct 1989American Cyanamid CompanyPartially absorbable prosthetic tubular article having an external support
US4915893 *15 Jul 198310 Apr 1990Medtronic, Inc.Method of preparing polyester filament material
US4997440 *10 Aug 19905 Mar 1991American Cyanamid CompanyVascular graft with absorbable and nonabsorbable components
US5098779 *25 Jun 199024 Mar 1992W. L. Gore & Associates, Inc.Carvable implant material
US5108424 *28 Jan 199128 Apr 1992Meadox Medicals, Inc.Collagen-impregnated dacron graft
US5110852 *27 Oct 19885 May 1992Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US5141522 *21 Jan 199225 Aug 1992American Cyanamid CompanyComposite material having absorbable and non-absorbable components for use with mammalian tissue
US5147374 *5 Dec 199115 Sep 1992Alfredo FernandezProsthetic mesh patch for hernia repair
US5178630 *26 May 199212 Jan 1993Meadox Medicals, Inc.Ravel-resistant, self-supporting woven graft
US5197977 *30 Apr 199230 Mar 1993Meadox Medicals, Inc.Drug delivery collagen-impregnated synthetic vascular graft
US5201745 *15 Aug 199113 Apr 1993ImedexVisceral surgery patch
US5207670 *9 Dec 19914 May 1993Rare Earth Medical, Inc.Photoreactive suturing of biological materials
US5282823 *19 Mar 19921 Feb 1994Medtronic, Inc.Intravascular radially expandable stent
US5282846 *29 Apr 19921 Feb 1994Meadox Medicals, Inc.Ravel-resistant, self-supporting woven vascular graft
US5282848 *19 Apr 19931 Feb 1994Meadox Medicals, Inc.Self-supporting woven vascular graft
US5282860 *8 Oct 19921 Feb 1994Olympus Optical Co., Ltd.Stent tube for medical use
US5326355 *24 Aug 19925 Jul 1994American Cyanamid CompanyComposite material having absorbable and nonabsorbable components for use with mammalian tissue
US5383925 *14 Sep 199224 Jan 1995Meadox Medicals, Inc.Three-dimensional braided soft tissue prosthesis
US5385156 *27 Aug 199331 Jan 1995Rose Health Care SystemsDiagnostic and treatment method for cardiac rupture and apparatus for performing the same
US5385580 *21 Sep 199231 Jan 1995Meadox Medicals, Inc.Self-supporting woven vascular graft
US5423849 *15 Jan 199313 Jun 1995Target Therapeutics, Inc.Vasoocclusion device containing radiopaque fibers
US5443496 *15 Oct 199322 Aug 1995Medtronic, Inc.Intravascular radially expandable stent
US5458636 *20 Jul 199417 Oct 1995U.S. Biomaterials CorporationProsthetic device for repair and replacement of fibrous connective tissue
US5487858 *31 Jan 199430 Jan 1996Meadox Medicals, Inc.Process of making self-supporting woven vascular graft
US5496364 *31 Jan 19945 Mar 1996Meadox Medicals, Inc.Self-supporting woven vascular graft
US5509931 *28 Jan 199423 Apr 1996Meadox Medicals, Inc.Ravel-resistant self-supporting woven vascular graft
US5540677 *24 Oct 199430 Jul 1996Rare Earth Medical, Inc.Endoscopic systems for photoreactive suturing of biological materials
US5542594 *6 Oct 19936 Aug 1996United States Surgical CorporationSurgical stapling apparatus with biocompatible surgical fabric
US5562725 *14 Sep 19928 Oct 1996Meadox Medicals Inc.Radially self-expanding implantable intraluminal device
US5562946 *2 Nov 19948 Oct 1996Tissue Engineering, Inc.Apparatus and method for spinning and processing collagen fiber
US5569239 *18 Aug 199429 Oct 1996Rare Earth Medical, Inc.Photoreactive suturing of biological materials
US5628788 *7 Nov 199513 May 1997Corvita CorporationSelf-expanding endoluminal stent-graft
US5651174 *27 Apr 199529 Jul 1997Medtronic, Inc.Intravascular radially expandable stent
US5665114 *12 Aug 19949 Sep 1997Meadox Medicals, Inc.Tubular expanded polytetrafluoroethylene implantable prostheses
US5693085 *26 Apr 19952 Dec 1997Scimed Life Systems, Inc.Stent with collagen
US5697969 *20 Sep 199516 Dec 1997Meadox Medicals, Inc.Vascular prosthesis and method of implanting
US5700269 *13 Nov 199523 Dec 1997Corvita CorporationEndoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability
US5716660 *31 May 199510 Feb 1998Meadox Medicals, Inc.Tubular polytetrafluoroethylene implantable prostheses
US5725522 *7 Jun 199510 Mar 1998Rare Earth Medical, Inc.Laser suturing of biological materials
US5741332 *19 Oct 199521 Apr 1998Meadox Medicals, Inc.Three-dimensional braided soft tissue prosthesis
US5741333 *3 Apr 199621 Apr 1998Corvita CorporationSelf-expanding stent for a medical device to be introduced into a cavity of a body
US5800541 *8 Jan 19971 Sep 1998Collagen CorporationCollagen-synthetic polymer matrices prepared using a multiple step reaction
US5824034 *5 Jun 199520 Oct 1998Meadox Medicals, Inc.Method for repositioning a radially self-expanding implantable intraluminal device
US5849037 *3 Apr 199615 Dec 1998Corvita CorporationSelf-expanding stent for a medical device to be introduced into a cavity of a body, and method for its preparation
US5851230 *18 Oct 199622 Dec 1998Meadox Medicals, Inc.Vascular graft with a heparin-containing collagen sealant
US5851290 *22 May 199622 Dec 1998Tissue Engineering, Inc.Apparatus for spinning and processing collagen fiber
US5908427 *30 May 19971 Jun 1999United States Surgical CorporationSurgical stapling apparatus and method
US5911942 *2 Nov 199515 Jun 1999Tissue Engineering, Inc.Method for spinning and processing collagen fiber
US5913894 *20 Oct 199522 Jun 1999Meadox Medicals, Inc.Solid woven tubular prosthesis
US5964774 *12 Sep 199712 Oct 1999United States Surgical CorporationSurgical stapling apparatus and method with surgical fabric
US5968091 *26 Nov 199719 Oct 1999Corvita Corp.Stents and stent grafts having enhanced hoop strength and methods of making the same
US5972007 *31 Oct 199726 Oct 1999Ethicon Endo-Surgery, Inc.Energy-base method applied to prosthetics for repairing tissue defects
US6042592 *4 Aug 199728 Mar 2000Meadox Medicals, Inc.Thin soft tissue support mesh
US6045560 *17 Jun 19964 Apr 2000United States Surgical CorporationSurgical stapling apparatus with biocompatible surgical fabric
US6090137 *5 Feb 199918 Jul 2000Meadox Medicals, Inc.Solid woven tubular prosthesis methods
US6090996 *4 Aug 199718 Jul 2000Collagen Matrix, Inc.Implant matrix
US6120539 *1 May 199719 Sep 2000C. R. Bard Inc.Prosthetic repair fabric
US6162247 *21 Dec 199819 Dec 2000Meadox Medicals, Inc.Vascular graft impregnated with a heparin-containing collagen sealant
US6177609 *10 Mar 199723 Jan 2001Meadox Medicals, Inc.Self-aggregating protein compositions and use as sealants
US619729629 Mar 19946 Mar 2001National Heart Research FundTissue equivalents
US622811127 Sep 19968 May 2001Bionx Implants OyBiodegradable implant manufactured of polymer-based material and a method for manufacturing the same
US623746030 Apr 199829 May 2001Corvita CorporationMethod for preparation of a self-expanding stent for a medical device to be introduced into a cavity of a body
US625111031 Mar 199926 Jun 2001Ethicon Endo-Surgery, Inc.Combined radio frequency and ultrasonic surgical device
US625724131 Mar 199910 Jul 2001Ethicon Endo-Surgery, Inc.Method for repairing tissue defects using ultrasonic radio frequency energy
US625812410 May 199910 Jul 2001C. R. Bard, Inc.Prosthetic repair fabric
US62705309 Jun 20007 Aug 2001C.R. Bard, Inc.Prosthetic repair fabric
US627389729 Feb 200014 Aug 2001Ethicon, Inc.Surgical bettress and surgical stapling apparatus
US628734431 Mar 199911 Sep 2001Ethicon Endo-Surgery, Inc.Method for repairing tissue defects using an ultrasonic device
US62966459 Apr 19992 Oct 2001Depuy Orthopaedics, Inc.Intramedullary nail with non-metal spacers
US632581030 Jun 19994 Dec 2001Ethicon, Inc.Foam buttress for stapling apparatus
US6334872 *7 Jul 19971 Jan 2002Organogenesis Inc.Method for treating diseased or damaged organs
US634806524 Jul 199819 Feb 2002Scimed Life Systems, Inc.Longitudinally flexible expandable stent
US635027715 Jan 199926 Feb 2002Scimed Life Systems, Inc.Stents with temporary retaining bands
US6368347 *23 Apr 19999 Apr 2002Sulzer Vascutek Ltd.Expanded polytetrafluoroethylene vascular graft with coating
US637566223 Nov 199923 Apr 2002Scimed Life Systems, Inc.Thin soft tissue surgical support mesh
US639105229 Oct 199721 May 2002Scimed Life Systems, Inc.Stent with collagen
US641648631 Mar 19999 Jul 2002Ethicon Endo-Surgery, Inc.Ultrasonic surgical device having an embedding surface and a coagulating surface
US648870518 Sep 20013 Dec 2002Meadox Medicals, Inc.Radially self-expanding implantable intraluminal device
US649765028 Jul 200024 Dec 2002C. R. Bard, Inc.Hernia prosthesis
US652434522 Oct 199725 Feb 2003Bionx Implants OySurgical implant
US65726504 Jun 19993 Jun 2003Organogenesis Inc.Bioengineered vascular graft support prostheses
US66525959 Jan 199825 Nov 2003Davol Inc.Method of repairing inguinal hernias
US666970618 Dec 200130 Dec 2003Scimed Life Systems, Inc.Thin soft tissue surgical support mesh
US670943622 May 200023 Mar 2004Depuy Orthopaedics, Inc.Non-metal spacers for intramedullary nail
US6726664 *6 Aug 200127 Apr 2004Optonol Ltd.Flow control device, introducer and method of implanting
US677008818 May 20003 Aug 2004Scimed Life Systems, Inc.Intravascular stent
US678352919 Oct 200131 Aug 2004Depuy Orthopaedics, Inc.Non-metal inserts for bone support assembly
US67869082 Aug 20017 Sep 2004Depuy Orthopaedics, Inc.Bone fracture support implant with non-metal spacers
US67902137 Jan 200214 Sep 2004C.R. Bard, Inc.Implantable prosthesis
US680852725 Mar 200226 Oct 2004Depuy Orthopaedics, Inc.Intramedullary nail with snap-in window insert
US68180143 Aug 199516 Nov 2004Scimed Life Systems, Inc.Longitudinally flexible expandable stent
US6827743 *25 Feb 20027 Dec 2004Sdgi Holdings, Inc.Woven orthopedic implants
US684632315 May 200325 Jan 2005Advanced Cardiovascular Systems, Inc.Intravascular stent
US6890351 *7 Sep 200110 May 2005Organogenesis Inc.Method for treating diseased or damaged organs
US691361911 Jul 20025 Jul 2005Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US692965925 Feb 200216 Aug 2005Scimed Life Systems, Inc.Method of preventing the dislodgment of a stent-graft
US696260322 Jun 20008 Nov 2005Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US697695225 Apr 200020 Dec 2005Vascutek LimitedExpanded polytetrafluoroethylene vascular graft with coating
US698198620 Sep 20003 Jan 2006Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US69867353 Mar 200317 Jan 2006Organogenesis Inc.Method of making a bioremodelable vascular graft prosthesis
US702213226 Feb 20024 Apr 2006Boston Scientific Scimed, Inc.Stents with temporary retaining bands
US704113111 Apr 20039 May 2006Organogenesis, Inc.Bioengineered vascular graft support prostheses
US704498227 Aug 200116 May 2006Michael MilbockerSurgical repair of tissue defects
US706010328 Feb 200313 Jun 2006Organogenesis Inc.Tissue repair fabric
US708113016 Apr 200225 Jul 2006Boston Scientific Scimed, Inc.Intravascular Stent
US71219993 Mar 200317 Oct 2006Organogenesis Inc.Method of preparing layered graft prostheses
US71568042 Dec 20022 Jan 2007Davol, Inc.Hernia prosthesis
US71603335 Sep 20039 Jan 2007Depuy Orthopaedics, Inc.Reinforced small intestinal submucosa
US716356315 Jul 200216 Jan 2007Depuy Products, Inc.Unitary surgical device and method
US720191715 Jul 200210 Apr 2007Depuy Products, Inc.Porous delivery scaffold and method
US720484820 Nov 199817 Apr 2007Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US72142423 Mar 20038 May 2007Organogenesis, Inc.Bioengineered tubular graft prostheses
US73262419 Aug 20015 Feb 2008Boston Scientific Scimed, Inc.Intravascular stent
US734160128 Jul 200411 Mar 2008Warsaw Orthopedic, Inc.Woven orthopedic implants
US735462722 Dec 20048 Apr 2008Depuy Products, Inc.Method for organizing the assembly of collagen fibers and compositions formed therefrom
US740481914 Sep 200029 Jul 2008C.R. Bard, Inc.Implantable prosthesis
US741048818 Feb 200512 Aug 2008Smith & Nephew, Inc.Hindfoot nail
US746821010 Dec 200323 Dec 2008Biosurface Engineering Technologies, Inc.Cross-linked heparin coatings and methods
US748181627 Oct 200327 Jan 2009Optonol Ltd.Intraocular implant, delivery device, and method of implantation
US751386520 Dec 20057 Apr 2009Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US751386629 Oct 20047 Apr 2009Depuy Products, Inc.Intestine processing device and associated method
US756923320 Apr 20054 Aug 2009Depuy Products, Inc.Hybrid biologic-synthetic bioabsorbable scaffolds
US7585319 *27 Sep 20048 Sep 2009Maquet Cardiovascular, LlcSelf-aggregating protein compositions and use as sealants
US759506228 Jul 200529 Sep 2009Depuy Products, Inc.Joint resurfacing orthopaedic implant and associated method
US761425819 Oct 200610 Nov 2009C.R. Bard, Inc.Prosthetic repair fabric
US765500930 Nov 20042 Feb 2010Smith & Nephew, Inc.Humeral nail
US76703107 Dec 20072 Mar 2010Optonol LtdFlow regulating implants
US768239230 Oct 200223 Mar 2010Depuy Spine, Inc.Regenerative implants for stabilizing the spine and devices for attachment of said implants
US770056319 Aug 200320 Apr 2010Biosurface Engineering Technologies, Inc.Synthetic heparin-binding factor analogs
US776695626 Nov 20033 Aug 2010Boston Scientific Scimed, Inc.Intravascular stent and assembly
US779908910 Oct 200621 Sep 2010Depuy Orthopaedics, Inc.Reinforced small intestinal submucosa
US781556211 Aug 200519 Oct 2010Boston Scientific Scimed, Inc.Tubular implantable sling and related delivery systems, methods and devices
US7819918 *29 Dec 200326 Oct 2010Depuy Products, Inc.Implantable tissue repair device
US78201721 Jun 200726 Oct 2010Biosurface Engineering Technologies, Inc.Laminin-derived multi-domain peptides
US782442026 May 20042 Nov 2010C.R. Bard, Inc.Implantable prosthesis
US782470125 Feb 20032 Nov 2010Ethicon, Inc.Biocompatible scaffold for ligament or tendon repair
US786253125 Jun 20044 Jan 2011Optonol Ltd.Flow regulating implants
US787144011 Dec 200618 Jan 2011Depuy Products, Inc.Unitary surgical device and method
US787529629 Nov 200725 Jan 2011Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US79004845 Nov 20098 Mar 2011C.R. Bard, Inc.Prosthetic repair fabric
US79014615 Dec 20038 Mar 2011Ethicon, Inc.Viable tissue repair implants and methods of use
US790988624 Mar 200622 Mar 2011Organogenesis, Inc.Tissue repair fabric
US7914808 *15 Jul 200229 Mar 2011Depuy Products, Inc.Hybrid biologic/synthetic porous extracellular matrix scaffolds
US792761926 Apr 200619 Apr 2011Promethean Surgical Devices LlcIn situ bulking composition
US798186222 Jun 200719 Jul 2011Biosurface Engineering Technologies, Inc.Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis
US798871710 Nov 20032 Aug 2011Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US798872020 Jul 20072 Aug 2011Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US8012205 *15 Jul 20026 Sep 2011Depuy Products, Inc.Cartilage repair and regeneration device
US801686728 Oct 200413 Sep 2011Depuy Mitek, Inc.Graft fixation device and method
US802141425 Jul 200220 Sep 2011Boston Scientific Scimed, Inc.Intravascular stent
US802589615 Jul 200227 Sep 2011Depuy Products, Inc.Porous extracellular matrix scaffold and method
US80340167 Dec 200711 Oct 2011Optonol, Ltd.Flow regulating implants and methods of implanting
US807079228 Mar 20026 Dec 2011Boston Scientific Scimed, Inc.Stent
US809252915 Jul 200210 Jan 2012Depuy Products, Inc.Meniscus regeneration device
US810157024 May 201024 Jan 2012Biosurface Engineering Technologies, Inc.Single branch heparin-binding growth factor analogs
US810989611 Feb 20087 Feb 2012Optonol Ltd.Devices and methods for opening fluid passageways
US811414615 Mar 200414 Feb 2012Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US813768620 Apr 200420 Mar 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US813770229 Dec 201020 Mar 2012Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US81424895 Sep 200827 Mar 2012Boston Scientific Scimed, Inc.Flexible and expandable stent
US81637176 Oct 200924 Apr 2012Biosurface Engineering Technologies, Inc.Dual chain synthetic heparin-binding growth factor analogs
US818254510 Jul 200822 May 2012C.R. Bard, Inc.Implantable prosthesis
US819276323 Jul 20085 Jun 2012Cook Biotech IncorporatedProcessed ECM materials with enhanced component profiles
US822178029 Jun 200617 Jul 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US822671530 Jun 200324 Jul 2012Depuy Mitek, Inc.Scaffold for connective tissue repair
US822741123 Feb 200624 Jul 2012BioSurface Engineering Technologies, IncleFGF growth factor analogs
US8231930 *4 Aug 200931 Jul 2012Maquet Cardiovascular, LlcSelf-aggregating protein compositions and use as sealants
US828254224 Feb 20099 Oct 2012Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US831345426 Mar 201020 Nov 2012Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
US833753715 Jul 200225 Dec 2012Depuy Products, Inc.Device from naturally occurring biologically derived materials
US834899221 Aug 20018 Jan 2013Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US836678714 Jun 20025 Feb 2013Depuy Products, Inc.Hybrid biologic-synthetic bioabsorbable scaffolds
US844956115 Feb 200728 May 2013Depuy Mitek, LlcGraft fixation device combination
US844959721 Nov 201128 May 2013Boston Scientific Scimed, Inc.Longitudinally flexible expandable stent
US84860867 Nov 201116 Jul 2013Optonol, LtdFlow regulating implant, method of manufacture, and delivery device
US849697027 Feb 201230 Jul 2013Depuy Mitek, LlcConformable tissue repair implant capable of injection delivery
US85413723 Jan 201124 Sep 2013Cook Biotech IncorporatedIsolated extracellular matrix material including subserous fascia
US856266517 Dec 200222 Oct 2013Boston Scientific Scimed, Inc.Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US859193028 Apr 200826 Nov 2013Cook Biotech IncorporatedGrowth factor modified extracellular matrix material preparation and methods for preparation and use thereof
US86172064 Oct 201031 Dec 2013Covidien LpWound closure device
US86284642 Oct 201214 Jan 2014Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US863706621 Sep 201028 Jan 2014Depuy Mitek, LlcBiocompatible scaffold for ligament or tendon repair
US86417751 Feb 20114 Feb 2014Depuy Mitek, LlcViable tissue repair implants and methods of use
US866308628 Sep 20104 Mar 2014Cook Biotech IncorporatedMedical reinforcement graft
US866331322 Sep 20114 Mar 2014Boston Scientific Scimed, Inc.Low strain high strength stent
US869125916 Nov 20058 Apr 2014Depuy Mitek, LlcReinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US872814720 Dec 201120 May 2014Boston Scientific LimitedLongitudinally flexible expandable stent
US87903882 Mar 201229 Jul 2014Boston Scientific Scimed, Inc.Stent with reduced profile
US879538410 Jan 20085 Aug 2014Cook Biotech IncorporatedImplantable devices useful for reinforcing a surgically created stoma
US879621219 Jul 20115 Aug 2014Biosurface Engineering Technologies, Inc.Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
US880177326 Mar 201212 Aug 2014Boston Scientific Scimed, Inc.Flexible and expandable stent
US88950458 May 201225 Nov 2014Depuy Mitek, LlcMethod of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US895637827 Feb 200917 Feb 2015Cook Biotech IncorporatedCoated embolization device
US904445526 Jul 20132 Jun 2015Cook Biotech IncorporatedIsolated extracellular matrix material including subserous fascia
US90725862 Oct 20097 Jul 2015C.R. Bard, Inc.Implantable prosthesis
US907877814 Sep 201114 Jul 2015Boston Scientific Scimed, Inc.Intravascular stent
US917377411 Sep 20123 Nov 2015Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
US91801459 Oct 201310 Nov 2015Mimedx Group, Inc.Compositions and methods for recruiting and localizing stem cells
US9186053 *11 Apr 201317 Nov 2015Covidien LpMethods of using light to repair hernia defects
US92113628 Jun 201215 Dec 2015Depuy Mitek, LlcScaffold for connective tissue repair
US9308068 *2 Dec 200812 Apr 2016Sofradim ProductionImplant for parastomal hernia
US944588327 Dec 201220 Sep 2016Sofradim ProductionBarbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US944592615 Aug 200820 Sep 2016Boston Scientific Scimed, Inc.Intravascular stent
US9468708 *28 Oct 201018 Oct 2016Biom'upComposite matrix
US949992725 Sep 201322 Nov 2016Sofradim ProductionMethod for producing a prosthesis for reinforcing the abdominal wall
US951117122 Nov 20106 Dec 2016Depuy Mitek, LlcBiocompatible scaffolds with tissue fragments
US95266031 Oct 201227 Dec 2016Covidien LpReversible stiffening of light weight mesh
US955488716 Mar 201231 Jan 2017Sofradim ProductionProsthesis comprising a three-dimensional and openworked knit
US962284329 Jun 201218 Apr 2017Sofradim ProductionUmbilical hernia prosthesis
US966235517 Jan 201430 May 2017Mimedx Group, Inc.Methods for treating cardiac conditions
US967025818 Aug 20166 Jun 2017Ferring B.V.Positive modulator of bone morphogenic protein-2
US975083725 Sep 20135 Sep 2017Sofradim ProductionHaemostatic patch and method of preparation
US20020049503 *27 Aug 200125 Apr 2002Michael MilbockerSurgical repair of tissue defects
US20020095208 *28 Mar 200218 Jul 2002Scimed Life Systems, Inc.Stent
US20020103542 *18 Sep 20011 Aug 2002Bilbo Patrick R.Methods for treating a patient using a bioengineered flat sheet graft prostheses
US20020116049 *9 Jan 200222 Aug 2002Scimed Life Systems, Inc.Stent
US20020123750 *25 Feb 20025 Sep 2002Lukas EisermannWoven orthopedic implants
US20030023316 *14 Jun 200230 Jan 2003Brown Laura JeanHybrid biologic-synthetic bioabsorable scaffolds
US20030033021 *15 Jul 200213 Feb 2003Plouhar Pamela LynnCartilage repair and regeneration scaffold and method
US20030079329 *9 Dec 20021 May 2003Ira YaronFlow regulating implant, method of manufacture, and delivery device
US20030083736 *3 Aug 19951 May 2003Brian J. BrownLongitudinally flexible expandable stent
US20030130747 *3 Mar 200310 Jul 2003Organogenesis, Inc.Bioengineered flat sheet graft prostheses
US20030149472 *7 Mar 20037 Aug 2003Leonard PinchukModular endluminal stent-grafts and methods for their use
US20030158607 *28 Feb 200321 Aug 2003Carr Robert M.Tissue repair fabric
US20030167088 *3 Mar 20034 Sep 2003Organogenesis, Inc.Bioengineered vascular graft prostheses
US20030171824 *3 Mar 200311 Sep 2003Organogenesis, Inc.Bioengineered tubular graft prostheses
US20030195618 *11 Apr 200316 Oct 2003Organogenesis, Inc.Bioengineered vascular graft support prostheses
US20040059431 *5 Sep 200325 Mar 2004Plouhar Pamela L.Reinforced small intestinal submucosa
US20040087505 *19 Aug 20036 May 2004Pena Louis A.Synthetic heparin-binding factor analogs
US20040088048 *27 Oct 20036 May 2004Jacob RichterIntraocular implant, delivery device, and method of implantation
US20040176834 *15 Mar 20049 Sep 2004Brown Brian J.Longitudinally flexible expandable stent
US20040220574 *15 Jul 20024 Nov 2004Pelo Mark JosephDevice from naturally occuring biologically derived materials
US20040230288 *17 Apr 200218 Nov 2004Rosenthal Arthur L.Medical devices adapted for controlled in vivo structural change after implantation
US20050038520 *11 Aug 200317 Feb 2005Francois BinetteMethod and apparatus for resurfacing an articular surface
US20050043733 *28 Jul 200424 Feb 2005Lukas EisermannWoven orthopedic implants
US20050085901 *27 Sep 200421 Apr 2005Dan CastroSelf-aggregating protein compostions and use as sealants
US20050125077 *5 Dec 20039 Jun 2005Harmon Alexander M.Viable tissue repair implants and methods of use
US20050182484 *12 Feb 200418 Aug 2005Patel Umesh H.Hybrid grafts
US20050192600 *24 Feb 20051 Sep 2005Enrico NicoloInguinal hernia repair prosthetic
US2005023296720 Apr 200420 Oct 2005Kladakis Stephanie MNonwoven tissue scaffold
US20060034943 *11 Oct 200516 Feb 2006Technology Innovations LlcProcess for treating a biological organism
US20060100717 *23 Nov 200511 May 2006Organogenesis, Inc.Bioengineered vascular graft prostheses
US20060147371 *23 Feb 20056 Jul 2006Tuszynski Jack AWater-soluble compound
US20060198816 *26 Apr 20067 Sep 2006Milbocker Michael TIn situ bulking composition
US20060199764 *23 Feb 20067 Sep 2006Biosurface Engineering Technologies, Inc.FGF growth factor analogs
US20070038017 *11 Aug 200515 Feb 2007Boston Scientific Scimed, Inc.Tubular implantable sling and related delivery systems, methods and devices
US20070112360 *15 Nov 200517 May 2007Patrick De DeyneBioprosthetic device
US20070135906 *5 Oct 200614 Jun 2007Badylak Stephen FStent with collagen
US20070150059 *22 Dec 200528 Jun 2007Depuy Spine, Inc.Methods and devices for intervertebral augmentation using injectable formulations and enclosures
US20070150063 *22 Dec 200528 Jun 2007Depuy Spine, Inc.Devices for intervertebral augmentation and methods of controlling their delivery
US20070150064 *22 Dec 200528 Jun 2007Depuy Spine, Inc.Methods and devices for intervertebral augmentation
US20080063622 *22 Jun 200713 Mar 2008Biosurface Engineering Technologies, Inc.Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis
US20080071385 *29 Nov 200720 Mar 2008Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US20080125691 *7 Dec 200729 May 2008Optonol Ltd.Flow regulating implants
US20080160169 *21 Dec 20073 Jul 2008Zamora Paul OCoating device and method for coating medical device with bioactive peptide
US20080166392 *31 Jan 200810 Jul 2008Zamora Paul OPositive Modulator of Bone Morphogenic Protein-2
US20080167729 *10 Jan 200810 Jul 2008Nelson Christopher MImplantable devices useful for reinforcing a surgically created stoma
US20080227696 *21 Feb 200618 Sep 2008Biosurface Engineering Technologies, Inc.Single branch heparin-binding growth factor analogs
US20080286268 *23 Jul 200820 Nov 2008Johnson Chad EProcessed ecm materials with enhanced component profiles
US20080299171 *28 Apr 20084 Dec 2008Hiles Michael CGrowth factor modified extracellular matrix material and methods for preparation and use thereof
US20080319531 *5 Sep 200825 Dec 2008Boston Scientific Scimed, Inc.Flexible and expandable stent
US20090036996 *3 Aug 20075 Feb 2009Roeber Peter JKnit PTFE Articles and Mesh
US20090105753 *26 Aug 200523 Apr 2009Prodesco, Inc.Sutures and methods of making the same
US20090112236 *15 Oct 200830 Apr 2009Tyco Healthcare Group LpFilament-Reinforced Composite Fiber
US20090142400 *30 May 20084 Jun 2009Hiles Michael CAnalgesic coated medical product
US20090156893 *24 Feb 200918 Jun 2009Boston Scientific Scimed, Inc.Flattened tubular mesh sling and related methods
US20090187197 *1 Aug 200823 Jul 2009Roeber Peter JKnit PTFE Articles and Mesh
US20090192528 *29 Jan 200830 Jul 2009Biomet Biologics, Inc.Method and device for hernia repair
US20090204053 *11 Feb 200813 Aug 2009Optonol Ltd.Devices and methods for opening fluid passageways
US20090270978 *27 Feb 200929 Oct 2009Virkler Joel ACoated embolization device
US20090297692 *4 Aug 20093 Dec 2009Maquet Cardiovascular, LlcSelf-aggregating protein compositions and use as sealants
US20100015868 *2 Jul 200921 Jan 2010Philippe GravagnaReinforced composite implant
US20100174253 *11 Jun 20088 Jul 2010Convatec Technologies Inc.Ostomy Appliance
US20100198236 *2 Feb 20105 Aug 2010Ralph ZipperSurgical Meshes and Methods of Use
US20100203023 *16 Apr 201012 Aug 2010Johnson Chad EEnhanced compositions containing cells and extracellular matrix materials
US20100274259 *26 Mar 201028 Oct 2010Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
US20100298218 *24 May 201025 Nov 2010Biosurface Engineering Technologies, Inc.Single Branch Heparin-Binding Growth Factor Analogs
US20110077455 *28 Sep 201031 Mar 2011Mark DuncanMedical reinforcement graft
US20110087271 *4 Oct 201014 Apr 2011Timothy SargeantWound Closure Device
US20110087272 *4 Oct 201014 Apr 2011Timothy SargeantWound Closure Device
US20110087273 *4 Oct 201014 Apr 2011Tyco Healthcare Group LpWound Closure Device
US20110087274 *4 Oct 201014 Apr 2011Tyco Healtcare Group LP, New Haven, CtWound Closure Device
US20110135700 *31 Jan 20119 Jun 2011Promethean Surgical Devices, Inc.In situ bulking composition
US20110152196 *3 Jan 201123 Jun 2011Bhavin ShahIsolated extracellular matrix material including subserous fascia
US20120253473 *28 Oct 20104 Oct 2012Biom'upComposite matrix
US20130296657 *11 Apr 20137 Nov 2013Covidien LpMethods of using light to repair hernia defects
US20140067058 *14 Aug 20136 Mar 2014Mimedx Group, Inc.Reinforced placental tissue grafts and methods of making and using the same
USRE4450112 Aug 201017 Sep 2013Smith & Nephew, Inc.Hindfoot nail
USRE4600813 Sep 201224 May 2016Smith & Nephew, Inc.Hindfoot nail
USRE4607830 May 201226 Jul 2016Smith & Nephew, Inc.Hindfoot nail
CN102781490A *28 Oct 201014 Nov 2012比奥马普公司Composite matrix
DE3503126A1 *30 Jan 19851 Aug 1985Meadox Medicals IncArzneimittel abgebender kollagenbeschichteter synthetischer gefaessersatz
DE3503127A1 *30 Jan 19851 Aug 1985Meadox Medicals IncKollagenbeschichteter synthetischer gefaessersatz
DE4128611A1 *28 Aug 19915 Mar 1992Meadox Medicals IncAusfransfestes, selbsttragendes, gewobenes gefaessimplantat
DE4128611C3 *28 Aug 199118 Apr 2002Meadox Medicals IncAusfransfestes, selbsttragendes, gewobenes Gefäßimplantat und Verfahren zu seiner Herstellung
EP0103005A1 *16 Feb 198321 Mar 1984SCHENCK, Robert R.Method and apparatus for anastomosing blood vessels
EP0103005A4 *16 Feb 198324 Oct 1985Robert R SchenckMethod and apparatus for anastomosing blood vessels.
EP0129428A2 *15 Jun 198427 Dec 1984Robert Roy SchenkDevices for joining anatomical structures
EP0129428A3 *15 Jun 198415 Jan 1986Robert Roy SchenkDevices for joining anatomical structures
EP0466105A2 *9 Jul 199115 Jan 1992Corvita CorporationComposite biosynthetic graft
EP0466105A3 *9 Jul 199117 Mar 1993Corvita CorporationComposite biosynthetic graft
EP0587461A2 *14 Jun 199316 Mar 1994Terumo Kabushiki KaishaArtificial blood vessel
EP0587461A3 *14 Jun 199318 May 1994Terumo CorpArtificial blood vessel
EP0943345A1 *19 Nov 199722 Sep 1999SHIMIZU, YasuhikoArtificial esophagus
EP0943345A4 *19 Nov 199727 Dec 2000Tapic Int Co LtdArtificial esophagus
WO1982001647A1 *30 Oct 198127 May 1982Robert L KasterVascular graft
WO1983003536A1 *18 Apr 198327 Oct 1983Massachusetts Inst TechnologyA multilayer bioreplaceable blood vessel prosthesis
WO1984000540A1 *28 Jul 198316 Feb 1984Jolla Cancer Res FoundPolypeptide
WO1992003107A127 Aug 19915 Mar 1992Meadox Medicals, Inc.Self-supporting woven vascular graft
WO1998018408A122 Oct 19977 May 1998Bionix Implants OySurgical implant
WO2001080918A125 Apr 20001 Nov 2001Sulzer Vascutek LimitedExpanded polytetrafluoroethylene vascular graft with coating
WO2003034945A1 *23 Oct 20021 May 2003Katsuko SakaiArtificial vessel and process for producing the same
WO2004093932A1 *21 Apr 20044 Nov 2004Verigen AgA seeded tear resistant scaffold
WO2011079976A1 *28 Oct 20107 Jul 2011Biom'upComposite matrix
WO2017079659A1 *4 Nov 201611 May 2017Poly-Med, Inc.Time dependent physiologic tissue scaffold
Classifications
U.S. Classification606/151, 427/398.1, 139/387.00R, 427/338, 623/1.38, 606/229
International ClassificationA61F2/04, A61L27/48, A61F2/06
Cooperative ClassificationA61F2/06, A61L27/48, A61F2/04
European ClassificationA61L27/48, A61F2/06, A61F2/04